First Phase II Hurdle Jumped, Chelsea’s Methotrexate Challenger Ready To Be Wooed
This article was originally published in The Pink Sheet Daily
Executive Summary
Company has about a year of cash, and hopes positive data from the small trial is enough to snag a partner.